Income Statement Coral Laboratories Limited

Stocks

CORALAB6

INE683E01017

Pharmaceuticals

Market Closed - Bombay S.E. 06:02:28 2026-09-01 EDT			5-day change	1st Jan Change
596.10 ^INR	-4.19%		-8.90%	+35.94%

08-14	Coral Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-30	Coral Laboratories Limited Recommends Final Dividend for the Financial Year 2025-2026	CI

6678f8f695487.rJblaGl9lw2oq12D8UaEeAvkdg2sHCfkxYEYzTomWdQ.nf2DDiIv5XX54gmwhynGHHLSMTXnJHLdj_hsvV1yA732oYQPPTzfOMqTBA

Published financial data: CORAL LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
Revenues	966M	756M	781M	837M	1.15B
Other Revenues, Total	-	-	-	-	-
Total Revenues	966M	756M	781M	837M	1.15B
Cost of Goods Sold, Total	522M	408M	468M	381M	541M
Gross Profit	444M	348M	313M	456M	609M
Selling General & Admin Expenses, Total	129M	118M	113M	121M	151M
Depreciation & Amortization - (IS)	19.83M	19.91M	21.8M	19.76M	20.11M
Other Operating Expenses	152M	145M	158M	168M	192M
Other Operating Expenses, Total	301M	282M	293M	309M	363M
Operating Income	143M	65.97M	20.73M	146M	246M
Interest Expense, Total	-425K	-1.41M	-3.38M	-2K	-976K
Interest And Investment Income	19.54M	17.49M	17.87M	33.56M	48.39M
Net Interest Expenses	19.11M	16.08M	14.49M	33.56M	47.41M
Currency Exchange Gains (Loss)	5K	13.83M	32.35M	9.51M	14.88M
Other Non Operating Income (Expenses)	13.99M	13.08M	14.31M	19.78M	24.15M
EBT, Excl. Unusual Items	176M	109M	81.88M	209M	332M
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Insurance Settlements	-	-	-	-	-
Other Unusual Items	187K	9.59M	381K	-1.64M	-7.7M
EBT, Incl. Unusual Items	176M	119M	82.26M	207M	325M
Income Tax Expense	40.58M	28.1M	17.81M	49.43M	83.15M
Earnings From Continuing Operations	136M	90.46M	64.45M	158M	242M
Net Income to Company	136M	90.46M	64.45M	158M	242M
Net Income - (IS)	136M	90.46M	64.45M	158M	242M
Net Income to Common Incl Extra Items	136M	90.46M	64.45M	158M	242M
Net Income to Common Excl. Extra Items	136M	90.46M	64.45M	158M	242M
Per Share Items
Net EPS - Basic	37.94	25.32	18.04	44.19	67.61
Basic EPS - Continuing Operations	37.94	25.32	18.04	44.19	67.61
Basic Weighted Average Shares Outstanding	3.57M	3.57M	3.57M	3.57M	3.57M
Net EPS - Diluted	37.94	25.32	18.04	44.19	67.61
Diluted EPS - Continuing Operations	37.94	25.32	18.04	44.19	67.61
Diluted Weighted Average Shares Outstanding	3.57M	3.57M	3.57M	3.57M	3.57M
Normalized Basic EPS	30.78	19.06	14.32	36.56	58.15
Normalized Diluted EPS	30.78	19.06	14.32	36.56	58.15
Dividend Per Share	-	-	-	2	1.5
Payout Ratio	-	-	-	-	2.96
Supplemental Items
EBITDA	162M	85.74M	42.45M	166M	266M
EBITA	143M	65.97M	20.73M	146M	246M
EBIT	143M	65.97M	20.73M	146M	246M
EBITDAR	165M	-	-	-	-
Total Revenues (As Reported)	1B	804M	850M	903M	1.24B
Effective Tax Rate - (Ratio)	23.04	23.7	21.65	23.84	25.61
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	45M	27.5M	18.2M	49.09M	83.3M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-4.42M	600K	-393K	338K	-154K
Normalized Net Income	110M	68.1M	51.18M	131M	208M
Non-Cash Pension Expense	278K	295K	285K	293K	311K
Supplemental Operating Expense Items
Advertising Expense	24.46M	5.24M	1.6M	9.41M	4.09M
Selling and Marketing Expenses	24.46M	5.24M	1.6M	9.41M	4.09M
Net Rental Expense, Total	2.72M	-	-	-	-
Imputed Operating Lease Interest Expense	152K	-	-	-	-
Imputed Operating Lease Depreciation	2.57M	-	-	-	-
Maintenance & Repair Expenses, Total	21.41M	10.86M	10.31M	8.58M	10.46M

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
Assets
Cash And Equivalents	23.24M	25.06M	61.3M	20.71M	34.06M
Short Term Investments	-	21.19M	12.38M	13.23M	12.03M
Trading Asset Securities, Total	-	196M	226M	244M	263M
Total Cash And Short Term Investments	23.24M	243M	300M	278M	309M
Accounts Receivable, Total	392M	381M	234M	282M	336M
Other Receivables	-	57K	-	-	-
Notes Receivable	135M	1.54M	2.02M	1.95M	2.34M
Total Receivables	526M	383M	236M	284M	339M
Inventory	217M	184M	125M	152M	98.71M
Prepaid Expenses	1.19M	1.97M	859K	867K	749K
Other Current Assets, Total	341M	497M	573M	824M	1.02B
Total Current Assets	1.11B	1.31B	1.24B	1.54B	1.77B
Gross Property Plant And Equipment	416M	472M	492M	499M	527M
Accumulated Depreciation	-207M	-227M	-249M	-266M	-285M
Net Property Plant And Equipment	209M	245M	243M	233M	242M
Long-term Investments	332M	244M	174M	240M	248M
Other Intangibles, Total	254K	185K	177K	632K	674K
Loans Receivable Long-Term	15.76M	3.5M	3.5M	3.5M	3.5M
Other Long-Term Assets, Total	10.08M	98.04M	87.46M	41.04M	34.74M
Total Assets	1.68B	1.9B	1.74B	2.06B	2.29B
Liabilities
Accounts Payable, Total	148M	87.98M	41.34M	132M	66.23M
Accrued Expenses, Total	9.21M	13.65M	18.72M	13.66M	17.01M
Short-term Borrowings	62.54M	60.39M	-	-	35.59M
Current Income Taxes Payable	25.82M	27.5M	18.2M	49.09M	83.3M
Unearned Revenue Current, Total	26.04M	-	-	-	-
Other Current Liabilities	6.39M	65.66M	40.35M	53.84M	47.46M
Total Current Liabilities	278M	255M	119M	249M	250M
Pension & Other Post Retirement Benefits	3.66M	3.45M	3.46M	3.81M	4.09M
Deferred Tax Liability Non Current	25.15M	25.75M	25.36M	25.7M	25.54M
Other Non Current Liabilities	2.28M	54.06M	48.05M	3.34M	3.38M
Total Liabilities	309M	338M	195M	282M	283M
Common Stock, Total	35.73M	35.73M	35.73M	35.73M	35.73M
Retained Earnings	1.2B	1.29B	1.36B	1.52B	1.75B
Comprehensive Income and Other	127M	230M	153M	223M	225M
Total Common Equity	1.37B	1.56B	1.55B	1.77B	2.01B
Total Equity	1.37B	1.56B	1.55B	1.77B	2.01B
Total Liabilities And Equity	1.68B	1.9B	1.74B	2.06B	2.29B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.57M	3.57M	3.57M	3.57M	3.57M
ECS Total Common Shares Outstanding	3.57M	3.57M	3.57M	3.57M	3.57M
Book Value / Share	382.48	436.81	433.29	496.83	563.19
Tangible Book Value	1.37B	1.56B	1.55B	1.77B	2.01B
Tangible Book Value Per Share	382.4	436.75	433.24	496.65	563
Total Debt	62.54M	60.39M	0	0	35.59M
Net Debt	39.3M	-182M	-300M	-278M	-274M
Debt Equivalent of Unfunded Proj. Benefit Obligation	4.34M	4.4M	4.46M	4.76M	5.02M
Debt Equivalent Oper. Leases	21.78M	-	-	-	-
Equity Method Investments, Total	141M	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	137M	110M	87.1M	82.91M	64.08M
Inventories - Work In Process, Total	15.67M	15.83M	8.52M	31.77M	9.86M
Inventories - Finished Goods, Total	56.07M	48.79M	19.75M	27.8M	16.56M
Inventories - Others	8.27M	9.28M	9.67M	9.09M	8.2M
Land - (BS)	9.17M	-	-	-	-
Buildings, Total	114M	123M	136M	136M	138M
Machinery, Total	288M	332M	356M	363M	365M
Full Time Employees	151	168	109	142	197

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
Net Income	136M	90.46M	64.45M	158M	242M
Depreciation & Amortization - CF	19.65M	19.78M	21.72M	19.71M	19.97M
Depreciation & Amortization, Total	19.65M	19.78M	21.72M	19.71M	19.97M
Amortization of Deferred Charges, Total - (CF)	179K	131K	84K	45K	136K
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-1.36M	-3.73M	-
Other Operating Activities, Total	-13.9M	-45.16M	-18.88M	-33.47M	-32.68M
Change In Accounts Receivable	-47.51M	10.45M	147M	-47.72M	-54.49M
Change In Inventories	-23.76M	33.13M	58.58M	-26.53M	52.86M
Change In Accounts Payable	6.43M	-55.7M	-51.13M	90.28M	-66.17M
Change in Other Net Operating Assets	-65.46M	7.75M	-93.75M	-211M	-173M
Cash from Operations	11.17M	60.84M	127M	-54.65M	-12.22M
Capital Expenditure	-13.6M	-55.48M	-19.45M	-9.91M	-29.45M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-20.33M	-17.31M	1.82M	-4.29M
Other Investing Activities, Total	11.57M	15.3M	10.62M	22.08M	32.22M
Cash from Investing	-2.03M	-60.51M	-26.15M	13.99M	-1.52M
Short Term Debt Issued, Total	3.42M	2.9M	-	68K	35.2M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	3.42M	2.9M	-	68K	35.2M
Short Term Debt Repaid, Total	-	-	-60.88M	-	-
Total Debt Repaid	-	-	-60.88M	-	-
Common Dividends Paid	-	-	-	-	-7.14M
Common & Preferred Stock Dividends Paid	-	-	-	-	-7.14M
Other Financing Activities, Total	-425K	-1.41M	-3.38M	-2K	-976K
Cash from Financing	2.99M	1.49M	-64.26M	66K	27.08M
Miscellaneous Cash Flow Adjustments	-	-	-1K	-	-
Net Change in Cash	12.13M	1.82M	36.24M	-40.59M	13.34M
Supplemental Items
Cash Interest Paid	425K	1.41M	3.38M	2K	976K
Cash Income Tax Paid (Refund)	34.27M	43.69M	19.69M	48.85M	73.32M
Levered Free Cash Flow	-19.15M	-6.81M	67.1M	-93.83M	-86.53M
Unlevered Free Cash Flow	-18.89M	-5.93M	69.22M	-93.83M	-85.92M
Change In Net Working Capital	114M	11.58M	-53.91M	195M	230M
Net Debt Issued / Repaid	3.42M	2.9M	-60.88M	68K	35.2M

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
Profitability
Return on Assets	5.73	2.31	0.71	4.81	7.07
Return on Total Capital	6.75	2.7	0.82	5.5	8.04
Return On Equity %	10.74	6.18	4.15	9.5	12.76
Return on Common Equity	10.74	6.18	4.15	9.5	12.76
Margin Analysis
Gross Profit Margin %	45.94	46.03	40.13	54.45	52.99
SG&A Margin	13.36	15.54	14.46	14.51	13.17
EBITDA Margin %	16.83	11.34	5.43	19.82	23.12
EBITA Margin %	14.79	8.72	2.65	17.46	21.39
EBIT Margin %	14.79	8.72	2.65	17.46	21.39
Income From Continuing Operations Margin %	14.04	11.96	8.25	18.87	21
Net Income Margin %	14.04	11.96	8.25	18.87	21
Net Avail. For Common Margin %	14.04	11.96	8.25	18.87	21
Normalized Net Income Margin	11.39	9.01	6.55	15.61	18.06
Levered Free Cash Flow Margin	-1.98	-0.9	8.59	-11.22	-7.52
Unlevered Free Cash Flow Margin	-1.96	-0.78	8.86	-11.22	-7.47
Asset Turnover
Asset Turnover	0.62	0.42	0.43	0.44	0.53
Fixed Assets Turnover	4.56	3.33	3.2	3.52	4.84
Receivables Turnover (Average Receivables)	2.63	1.96	2.54	3.24	3.72
Inventory Turnover (Average Inventory)	2.55	2.04	3.03	2.76	4.32
Short Term Liquidity
Current Ratio	3.99	5.13	10.42	6.18	7.07
Quick Ratio	1.49	2.44	4.5	2.25	2.59
Operating Cash Flow to Current Liabilities	0.04	0.24	1.07	-0.22	-0.05
Days Sales Outstanding (Average Receivables)	139.03	186.51	143.76	112.9	98.13
Days Outstanding Inventory (Average Inventory)	143.24	179.07	120.44	132.85	84.48
Average Days Payable Outstanding	96.74	114.75	57.68	78.36	74.31
Cash Conversion Cycle (Average Days)	185.54	250.84	206.51	167.39	108.3
Long Term Solvency
Total Debt/Equity	4.58	3.87	-	-	1.77
Total Debt / Total Capital	4.38	3.73	-	-	1.74
Total Liabilities / Total Assets	18.44	17.82	11.21	13.7	12.31
EBIT / Interest Expense	336.07	46.75	6.12	73.06K	252
EBITDA / Interest Expense	382.3	60.77	12.54	82.91K	272.46
(EBITDA - Capex) / Interest Expense	350.3	21.45	6.79	77.96K	242.29
Total Debt / EBITDA	0.38	0.7	-	-	0.13
Net Debt / EBITDA	0.24	-2.13	-7.07	-1.68	-1.03
Total Debt / (EBITDA - Capex)	0.42	2	-	-	0.15
Net Debt / (EBITDA - Capex)	0.26	-6.02	-13.05	-1.78	-1.16
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	36.82	-21.7	3.32	7.09	37.47
Gross Profit, 1 Yr. Growth %	53.74	-21.55	-9.94	45.34	33.77
EBITDA, 1 Yr. Growth %	185.04	-47.23	-50.5	290.66	60.37
EBITA, 1 Yr. Growth %	284.72	-53.81	-68.58	604.86	68.33
EBIT, 1 Yr. Growth %	284.72	-53.81	-68.58	604.86	68.33
Earnings From Cont. Operations, 1 Yr. Growth %	90.1	-33.26	-28.75	144.97	52.99
Net Income, 1 Yr. Growth %	90.1	-33.26	-28.75	144.97	52.99
Normalized Net Income, 1 Yr. Growth %	92.98	-38.07	-24.86	155.2	59.08
Diluted EPS Before Extra, 1 Yr. Growth %	90.1	-33.26	-28.75	144.97	52.99
Accounts Receivable, 1 Yr. Growth %	13.81	-2.67	-38.55	20.38	19.33
Inventory, 1 Yr. Growth %	12.31	-15.28	-31.9	21.22	-34.87
Net Property, Plant and Equip., 1 Yr. Growth %	-2.71	17.15	-0.87	-4.15	4.09
Total Assets, 1 Yr. Growth %	16.12	13.34	-8.19	17.97	11.56
Tangible Book Value, 1 Yr. Growth %	18.15	14.21	-0.8	14.64	13.36
Common Equity, 1 Yr. Growth %	18.13	14.2	-0.8	14.66	13.36
Cash From Operations, 1 Yr. Growth %	-128.91	553.53	108.18	-143.15	-77.63
Capital Expenditures, 1 Yr. Growth %	-1.42	307.9	-64.94	-49.06	197.17
Levered Free Cash Flow, 1 Yr. Growth %	-77.62	-18.09	-1.09K	-239.83	-7.78
Unlevered Free Cash Flow, 1 Yr. Growth %	-77.84	-26.34	-1.27K	-235.55	-8.43
Dividend Per Share, 1 Yr. Growth %	-	-	-	-	-25
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.97	3.5	-10.06	5.19	21.33
Gross Profit, 2 Yr. CAGR %	11.63	9.83	-15.95	14.41	39.43
EBITDA, 2 Yr. CAGR %	13.58	22.65	-48.89	39.06	150.3
EBITA, 2 Yr. CAGR %	15.48	33.3	-61.9	48.82	244.46
EBIT, 2 Yr. CAGR %	15.48	33.3	-61.9	48.82	244.46
Earnings From Cont. Operations, 2 Yr. CAGR %	15.18	12.63	-31.04	32.12	93.59
Net Income, 2 Yr. CAGR %	15.18	12.63	-31.04	32.12	93.59
Normalized Net Income, 2 Yr. CAGR %	6.52	9.32	-31.78	38.48	101.48
Diluted EPS Before Extra, 2 Yr. CAGR %	15.18	12.63	-31.04	32.12	93.59
Accounts Receivable, 2 Yr. CAGR %	13.64	5.25	-22.66	-13.99	19.85
Inventory, 2 Yr. CAGR %	15.77	-2.46	-24.05	-9.15	-11.15
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.76	6.76	7.77	-2.52	-0.12
Total Assets, 2 Yr. CAGR %	11.08	14.72	2.01	4.07	14.72
Tangible Book Value, 2 Yr. CAGR %	9.61	16.17	6.44	6.64	14
Common Equity, 2 Yr. CAGR %	9.59	16.15	6.44	6.65	14.01
Cash From Operations, 2 Yr. CAGR %	12.48	25.5	268.85	-5.22	-68.93
Capital Expenditures, 2 Yr. CAGR %	-30.51	100.53	19.59	-57.74	23.04
Levered Free Cash Flow, 2 Yr. CAGR %	-44.61	-71.8	184.12	271.22	13.56
Unlevered Free Cash Flow, 2 Yr. CAGR %	-44.93	-73.63	193.29	297.88	11.41
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.45	-6.02	3.44	-4.67	15
Gross Profit, 3 Yr. CAGR %	5.7	-0.75	2.8	0.88	20.53
EBITDA, 3 Yr. CAGR %	1.67	-12.03	-9.36	0.68	45.83
EBITA, 3 Yr. CAGR %	0.87	-14.92	-17.66	0.76	55.06
EBIT, 3 Yr. CAGR %	0.87	-14.92	-17.66	0.76	55.06
Earnings From Cont. Operations, 3 Yr. CAGR %	2.89	-3.98	-3.31	5.22	38.74
Net Income, 3 Yr. CAGR %	2.89	-3.98	-3.31	5.22	38.74
Normalized Net Income, 3 Yr. CAGR %	-0.85	-11.1	-3.52	5.9	45.03
Diluted EPS Before Extra, 3 Yr. CAGR %	2.89	-3.98	-3.31	5.22	38.74
Accounts Receivable, 3 Yr. CAGR %	7.4	7.92	-12.03	-10.37	-4.08
Inventory, 3 Yr. CAGR %	7.29	4.32	-13.47	-11.24	-18.69
Net Property, Plant and Equip., 3 Yr. CAGR %	-0.41	3.47	4.15	3.64	-0.37
Total Assets, 3 Yr. CAGR %	6.12	11.83	6.51	7.08	6.51
Tangible Book Value, 3 Yr. CAGR %	5.52	11.12	10.21	9.1	8.83
Common Equity, 3 Yr. CAGR %	5.51	11.11	10.2	9.11	8.84
Cash From Operations, 3 Yr. CAGR %	-56.39	90.3	48.56	80.39	-41.43
Capital Expenditures, 3 Yr. CAGR %	-33.99	25.36	12.13	-10.02	-19.03
Levered Free Cash Flow, 3 Yr. CAGR %	-33.34	-52.22	-7.79	124.32	133.36
Unlevered Free Cash Flow, 3 Yr. CAGR %	-33.72	-54.34	-6.7	126.76	143.83
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.63	-3.51	-3.32	-1.69	10.26
Gross Profit, 5 Yr. CAGR %	6.73	-5.15	-3.56	5.05	16.13
EBITDA, 5 Yr. CAGR %	-0.31	-18.22	-22.78	5.66	36.07
EBITA, 5 Yr. CAGR %	-0.67	-21.34	-31.67	6.41	45.96
EBIT, 5 Yr. CAGR %	-0.67	-21.34	-31.67	6.41	45.96
Earnings From Cont. Operations, 5 Yr. CAGR %	1.8	-11.11	-12.33	9.1	27.64
Net Income, 5 Yr. CAGR %	1.8	-11.11	-12.33	9.1	27.64
Normalized Net Income, 5 Yr. CAGR %	0.22	-15.26	-14.62	6.15	29.53
Diluted EPS Before Extra, 5 Yr. CAGR %	1.8	-11.11	-12.33	9.1	27.64
Accounts Receivable, 5 Yr. CAGR %	7.09	4.46	-5.82	-1.45	-0.45
Inventory, 5 Yr. CAGR %	10.28	-2.4	-6.56	-1.29	-12.55
Net Property, Plant and Equip., 5 Yr. CAGR %	2.99	7.23	2.78	1.03	2.42
Total Assets, 5 Yr. CAGR %	13.37	7.69	4.46	8.66	9.72
Tangible Book Value, 5 Yr. CAGR %	14.26	7.42	5.89	9.31	11.71
Common Equity, 5 Yr. CAGR %	14.26	7.41	5.88	9.3	11.71
Cash From Operations, 5 Yr. CAGR %	-28.86	-10.8	-1.22	43.99	-20.56
Capital Expenditures, 5 Yr. CAGR %	8.75	22.53	-16.27	-18.85	16.37
Levered Free Cash Flow, 5 Yr. CAGR %	-16.84	-16.98	0.74	8.49	0.22
Unlevered Free Cash Flow, 5 Yr. CAGR %	-17.25	-19.05	1.3	8.54	0.16
Dividend Per Share, 5 Yr. CAGR %	-	-	-	0	-